Deanna Lites speaks to Dr. Goutman about why it's important to look at environmental factors in ALS, which will be part of the new ALS medical moonshot thanks to a $3.6 million grant from the NIH.
"We’ve had multi-millions of cases of COVID in this country. I mean let’s do the math, when 20 percent of those individuals – we’re talking about millions of individuals who have long COVID, those individuals are really impaired." Dr. Eva Feldman speaks to One Detroit's Bill Kubota on Detroit Public Television about Long COVID.
The American Neurological Association (ANA) honored Dr. Eva Feldman with the 2021 Raymond D. Adams Lectureship at their annual meeting.
"I don't know of one person in Ann Arbor who has individually done more in the fight against ALS than (Dr.) Bob Schoeni." Dr. Eva Feldman remembers her friend, colleague and ALS ally in a moving letter.
A multidisciplinary group of University of Michigan researchers will investigate environmental exposures, chosen as one of the first projects in a new National Institutes of Health amyotrophic lateral sclerosis initiative.
Associate Professor Benjamin Murdock, Ph.D., speaks about the immune system and ALS on the podcast for the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium.
A CDC-funded multidisciplinary effort at U-M will investigate air pollution as a major and modifiable risk factor for ALS and seek to identify therapy targets.
